CaVos Biotech uses a proprietary comparative genomics platform developed by Prof. Yuval Tabach at Harvard and HUJI to identify and develop novel disease related high resolution targets for various diseases.
The company was seeded by aMoon Velocity and The Israel Innovation Authority (IIA).